Skip to main content

Lewis Joseph's Form 4 filing

Mirati Therapeutics, Inc. (MRTX) · filed Aug 15, 2023

Accession no.
0000895345-23-000500
Filed
Aug 15, 2023, 9:39 PM ET
Trade date
Aug 11, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $35.0M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lewis JosephCIK 0001015747Other: See remarks
Fuglesang ChristopherCIK 0001465835Other: See remarks
Boxer Asset Management Inc.CIK 0001465836Other: See remarks
Boxer Capital, LLCCIK 0001465837Other: See remarks
Davis Aaron I.CIK 0001465914Other: See remarks
MVA Investors, LLCCIK 0001468223Other: See remarks
Dissanayake Shehan BharathaCIK 0001663609Other: See remarks

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 11, 2023Common StockPPurchaseAcquired+57,533$27.80+$1,599,417.4287,866IndirectDuplicate filing
Aug 11, 2023Common StockPPurchaseAcquired+1,201,440$27.80+$33,400,0323,201,440DirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)